Raia Drogasil S/A

Raia Drogasil S/A EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Raia Drogasil S/A (RADL3.SA) as of Nov 5, 2026 is 2.64 B BRL. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 4.17 B BRL — a change of -36.73% (lower).

EBITDA

2.64 BBRL

YoY

-36.73%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Raia Drogasil S/A is 2025 2.64 B BRL. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Raia Drogasil S/A was 2024 4.17 B BRL. It decreases by -36.73% lower compared to the previous year.

The Raia Drogasil S/A EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
721.51 M BRL
Jan 1, 2019
891.22 M BRL
Jan 1, 2020
894.72 M BRL
Jan 1, 2021
2.60 B BRL
Jan 1, 2022
3.31 B BRL
Jan 1, 2023
3.74 B BRL
Jan 1, 2024
4.17 B BRL
Jan 1, 2025
2.64 B BRL
The Raia Drogasil S/A EBITDA history
YEAREBITDAYoY
2.64 BBRL-36.73%
4.17 BBRL+11.40%
3.74 BBRL+13.00%
3.31 BBRL+27.46%
2.60 BBRL+190.39%
894.72 MBRL+0.39%
891.22 MBRL+23.52%
721.51 MBRL-36.18%
1.13 BBRL+15.36%
979.97 MBRL+34.51%
728.56 MBRL+55.72%
467.86 MBRL—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Raia Drogasil S/A Stock analysis

What does Raia Drogasil S/A do? Raia Drogasil SA is a Brazilian company specializing in the sale of pharmaceutical and personal care products. The company is based in São Paulo, Brazil, and operates throughout Latin America. Raia Drogasil was founded in 1905 and is now the largest retail company in Brazil specializing in the sale of drugs and personal care products. Raia Drogasil started as a small family business and over the years, through acquisitions and mergers, became one of the largest retailers in Brazil. The company opened its first pharmacy in São Paulo and expanded its presence throughout the entire territory of Brazil. Today, Raia Drogasil operates approximately 2,200 branches in over 25 states in Brazil. Raia Drogasil's innovative business model is focused on digitalized processes and customer service, ensuring a smooth and user-friendly experience for customers. The company has adapted its business operations in the past due to environmental changes and societal trends. For example, Raia Drogasil has recently strengthened its e-commerce business, allowing customers to conveniently and securely order from home. Raia Drogasil SA operates two different brands: Drogasil and Droga Raia. The Drogasil brand is established more in cities, while the Droga Raia brand is active in smaller towns. Both brand branches offer a wide range of health and beauty products, including drugs, supplements, cosmetics, and baby products. Products offered by Raia Drogasil include general health medications such as pain relievers, vitamins, and cough and cold remedies. Additionally, the company also offers a wide range of products for specific health issues, such as products for diabetics, skincare, and women's well-being. They also carry supplements for various needs, such as immune system support, cardiovascular issues, muscle building, and weight loss. Raia Drogasil also provides a wide selection of cosmetic products for body care and beauty, including skincare and haircare products, makeup, and perfumes. Another special offering is the baby and children's department, where you can find a variety of products for babies and children of all ages, such as baby creams, wipes, and milk powder. In summary, Raia Drogasil SA is one of the leading companies in the pharmacy and personal care industry in Brazil. The company specializes in providing health products to its customers and offers a wide range of products for various needs. This includes medications, supplements, cosmetic products, baby products, and much more. Raia Drogasil has also successfully adapted to ever-changing environmental conditions and societal trends to ensure a smooth and user-friendly experience for its customers. Raia Drogasil S/A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Raia Drogasil S/A stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Raia Drogasil S/A is 2.64 B BRL in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Raia Drogasil S/A changed from 4.17 B BRL to 2.64 B BRL, representing a -36.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Raia Drogasil S/A since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Raia Drogasil S/A historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Raia Drogasil S/A

All Key Metrics — Raia Drogasil S/A